Global impact of human immunodeficiency virus and AIDS

被引:71
作者
Gayle, KD [1 ]
Hill, GL [1 ]
机构
[1] Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1128/CMR.14.2.327-335.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This review provides information on the epidemiology, economic impact, and intervention strategies for the human immunodeficiency virus (HIV)/AIDS pandemic in developing countries. According to the World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS) at the end of 1999 an estimated 34.3 million people were living with HIV/AIDS. Most of the people living with HIV, 95% of the global total, live in developing countries. Examples of the impact of HIV/AIDS in Africa, Asia, Latin America, the Caribbean and the Newly Independent States provide insight into the demographics, modes of exposure, treatment and prevention options, and the economic effect of tire epidemic on the global community. The epidemic in each region of the world is influenced by the specific risk factors that ms associated with the spread of HIV/AIDS and the responses that have evolved to address it. These influences are important in developing HIV/AIDS policies and programs to effectively address the global pandemic.
引用
收藏
页码:327 / +
页数:10
相关论文
共 108 条
[1]   Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire:: a randomised trial [J].
Anglaret, X ;
Chêne, G ;
Attia, A ;
Toure, S ;
Lafont, S ;
Combe, P ;
Manlan, K ;
N'Dri-Yoman, T ;
Salamon, R .
LANCET, 1999, 353 (9163) :1463-1468
[2]  
[Anonymous], 1998, Wkly Epidemiol Rec, V73, P313
[3]  
[Anonymous], 1999, Wkly Epidemiol Rec, V74, P385
[4]  
[Anonymous], 1999, PREV HIV TRANSM MOTH
[5]  
[Anonymous], 1999, ACT EARL PREV AIDS C
[6]  
[Anonymous], 1993, World Development Report 1993: Investing in Healthl
[7]  
[Anonymous], AIDS WORLD
[8]  
ATTAWELL K, 1999, KNOWLEDGE PRACTICE S
[9]  
Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170
[10]   Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective [J].
Bell, JC ;
Rose, DN ;
Sacks, HS .
AIDS, 1999, 13 (12) :1549-1556